Skip to main content
Larisa Geskin, MD, Dermatology, New York, NY, New York-Presbyterian Hospital


Dermatology New York, NY

Associate Professor, Director, Cutaneous Oncology, Department of Dermatology, Columbia University

Dr. Geskin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Geskin's full profile

Already have an account?


  • Dr. Larisa Geskin is a dermatologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from University of Pittsburgh School of Medicine and has been in practice 19 years. She is experienced in cutaneous t-cell lymphoma, melanoma and cutaneous malignancies, complex medical dermatology, skin cancer screening, and primary cutaneous anaplastic large cell lymphoma.

Education & Training

  • University of Pittsburgh Medical Center
    University of Pittsburgh Medical CenterInternship, Internal Medicine, 1998 - 1999
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1998

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2022
  • PA State Medical License
    PA State Medical License 1999 - 2014
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations



  • Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL
    Larisa J Geskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019


  • Management Issues in Cutaneous Lymphoma 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019
  • Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides: Results from the MAVORIC study. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Despite Knowing the Skin Cancer Risk, Many Millennials Continue to Tan
    Despite Knowing the Skin Cancer Risk, Many Millennials Continue to TanJuly 3rd, 2019
  • Beating Back Skin Cancer
    Beating Back Skin CancerMay 17th, 2019
  • Skin Cancer Prevention Advocates Target Indoor Tanning
    Skin Cancer Prevention Advocates Target Indoor TanningJanuary 30th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations